Volume

5, 4 issues

Latest issue

5:3 online 28 August 2021

Next issue

5:4 scheduled for December 2021

Back volumes

From volume 1, 2017

ISSN print

2468-4562

ISSN online

2468-4570

Aims & Scope

Kidney Cancer is an international multidisciplinary journal to facilitate progress in understanding the epidemiology/etiology, genetics, molecular correlates, pathogenesis, pathobiology, and pharmacology of tumors of the kidney with the objective of improving diagnosis, treatment, and survivorship in patients. The journal is directed primarily at researchers and clinicians working on these areas, with some content aimed at patients/patient advocates with these conditions. With this objective in mind, the journal publishes original research reports, systematic and regular reviews, short communications, and letters-to-the-editor in basic science, translational research and clinical medicine. The journal is committed to the highest ethical standards and best practices, and prospective authors are encouraged to consult the relevant author instructions and policies on the website at the time of submission as these are updated regularly to reflect changing guidelines.

Editorial Board

Editors-in-Chief

Primo N. Lara, Jr., MD
University of California Davis Comprehensive Cancer Center
Sacramento, CA
USA
Email: kca@iospress.com

Peter Mulders, MD, PhD
Radboud UMC
Nijmegen
The Netherlands
Email: kca@iospress.com

Associate Editors

Neeraj Agarwal, MD
Huntsman Cancer Institute, University of Utah, Salt Lake City
USA

Laurence Albiges, MD, PhD
Gustave Roussy, Université Paris Saclay, Villejuif
France

Axel Bex, MD, PhD
Netherlands Cancer Institute, Amsterdam
The Netherlands

Toni K. Choueiri, MD
Dana-Farber Cancer Institute, Boston
USA

Enrique Grande, MD
MD Anderson Cancer Center Madrid, Madrid
Spain

Viktor Grünwald, MD
University Hospital Essen, Essen
Germany

Eric Jonasch, MD
The University of Texas MD Anderson Cancer Center, Houston
USA

Bradley C. Leibovich, MD
Mayo Clinic, Rochester
USA

Egbert Oosterwijk, PhD
Radboud UMC, Nijmegen
The Netherlands

Javier Puente, MD, PhD
Hospital Clinico Universitario San Carlos, Madrid
Spain

Sandy Srinivas, MD
Stanford University, Stanford
USA

Hirotsugu Uemura, MD, PhD
Kindai University Faculty of Medicine, Osaka
Japan

Social Media Editor

Neeraj Agarwal, MD
Huntsman Cancer Institute, University of Utah, Salt Lake City
USA

Associate Editors for Reviews

Enrique Grande, MD
MD Anderson Cancer Center Madrid, Madrid
Spain

Sumanta Pal, MD
City of Hope, Duarte
USA

Editor of Clinical Trials Corner

Mamta Parikh, MD
UC Davis Comprehensive Cancer Center, Sacramento
USA

Editorial Board

Hideyuki Akaza, MD
University of Tokyo, Tokyo
Japan

Georg A. Bjarnason, MD, FRCP(C)
Sunnybrook Odette Cancer Center, Toronto, ON
Canada

James Brugarolas, MD, PhD
University of Texas Southwestern Medical Center, Dallas, TX
USA

Ronald M. Bukowski, MD
Cleveland Clinic Foundation, Cleveland
USA

Steven C. Campbell, MD, PhD
Cleveland Clinic, Cleveland, OH
USA

Marc Dall’era, MD
UC Davis Comprehensive Cancer Center, Sacramento, CA
USA

Tanya B. Dorff, MD 
City of Hope, Duarte, CA
USA

Janice P. Dutcher, MD
Cancer Research Foundation, Chappaqua, NY
USA

Tim Eisen, PhD
University of Cambridge, Cambridge
United Kingdom

Bernard Escudier, MD
Institut Gustave Roussy, Villejuif
France

Robert A. Figlin, MD, FACP
Cedars-Sinai Medical Center, Los Angeles, CA
USA

Thomas (Tom) Flaig, MD
University of Colorado School of Medicine, Aurora, CO
USA

Jorge Garcia, MD
Cleveland Clinic, Cleveland, OH
USA

Dan George, MD
Duke University School of Medicine, Durham, NC
USA

Ugo De Giorgi, MD
Istituto Scientifico Romagnolo per lo Studio e la Cura dei Tumori, Meldola
Italy

Rudolfo De Guzman, MD
National Kidney and Transplant Institute, Metro Manila
Philippines

John Haanen, MD, PhD
Netherlands Cancer Institute, Amsterdam
The Netherlands

Naomi Haas, MD
University of Pennsylvania, Philadelphia, PA
USA

Hans Hammers, MD, PhD
University of Texas Southwestern, Dallas, TX
USA

Michael R. Harrison, MD
Duke Cancer Institute, Durham, NC, USA

Daniel Heng, MD, MPH
Tom Baker Cancer Center, Calgary, AB
Canada

Michelle S. Hirsch, MD, PhD
Brigham and Women's Hospital, Harvard Medical School, Boston, MA
USA

James J. Hsieh, MD, PhD
Washington University School of Medicine, St. Louis, MO
USA

Thomas Hutson, DO, PharmD
US Oncology/Baylor, Houston, TX
USA

Choung Soo Kim, MD, PhD
Asan Medical Center, Seoul
South Korea

Christian Kollmannsberger, MD
BC Cancer Agency, Vancouver, BC
Canada

James Larkin, MD, PhD
The Institute of Cancer Research, London
United Kingdom

Marston Linehan, MD
National Cancer Institute, Bethesda, MD
USA

Borje Ljungberg, MD, PhD
Umea University, Umea, Sweden

Axel S. Merseburger, MD, PhD
University Hospital Schleswig-Holstein, Lübeck
Germany

Moshe C. Ornstein, MD
Cleveland Clinic, Cleveland, OH
USA

Susanne Osanto, MD, PhD
Leiden University Medical Center, Leiden
The Netherlands

Stephane Oudard, MD, PhD
Hôpital Européen Georges Pompidou, Paris
France

Allan J. Pantuck, MD
UCLA Institute of Urologic Oncology, Los Angeles
USA

Elizabeth Plimack, MD
Fox Chase Cancer Center, Philadelphia, PA
USA

Camillo Porta, MD
IRCCS San Matteo University Hospital Foundation, Pavia
Italy

Thomas Powles, MD
The Royal Free NHS Trust and Barts Cancer Institute, London
United Kingdom

David I. Quinn, MBBS, PhD
University of Southern California Norris Comprehensive Cancer Center, Los Angeles, CA
USA

W. Kimryn Rathmell, MD, PhD
Vanderbilt-Ingram Cancer Center, Nashville, TN
USA

Bruce G. Redman, MD
University of Michigan, Ann Arbor, MI
SA

Brian Rini, MD
Cleveland Clinic, Cleveland, OH
USA

Paul Russo, MD
Memorial Sloan Kettering Cancer Center, New York, NY
USA

Christopher Ryan, MD
Oregon Health Science University, Portland, OR
SA

Manuela Schmidinger, MD
University of Austria, Vienna
Austria

Brian Shuch, MD
Yale School of Medicine/Smilow Cancer Center, New Haven, CT
USA

Ramaprasad Srinivasan, MD, PhD
National Cancer Institute, Bethesda, MD
USA

Walter Stadler, MD
University of Chicago, Chicago, IL
USA

Mark Stein, MD
Rutgers, The State University of New Jersey, New Brunswick, NJ
USA

Cora N. Sternberg, MD
San Camillo and Forlanini Hospitals, Rome
Italy

Cezary Szczylik, MD, PhD
Oncology Military Medical Institute, Warsaw
Poland

Nizar M. Tannir, MD
MD Anderson Cancer Center, Houston, TX
USA

Yoshihiko Tomita, MD, PhD
Niigata University, Niigata
Japan

Ilya Tsimafeyeu, MD
Kidney Cancer Research Bureau, Russian Society of Clinical Oncology, Moscow
Russia

Robert G. Uzzo, MD
Fox Chase Cancer Center, Philadelphia, PA
USA

Ulka Vaishampayan, MD
University of Michigan, Rogel Cancer Center, Ann Arbor, MI
USA

Gretchen Vaughan
Kidney Cancer Association, Chicago, IL
USA

Guillermo de Velasco, MD, PhD
Hospital Universitario 12 de Octubre, Madrid
Spain

Nicholas J. Vogelzang, MD
Comprehensive Cancer Centers of Nevada (CCCN), Las Vegas, NV
USA

Martin H. Voss, MD
Memorial Sloan Kettering Cancer Center, New York, NY
USA

Stenio Zequi, MD, PhD
AC Camargo Cancer Center, Sao Paulo
Brazil

Patricia Zondervan, MD, PhD
Amsterdam UMC, Amsterdam
The Netherlands

Author Guidelines

By submitting my article to this journal, I agree to the Author Copyright Agreement, the IOS Press Ethics Policy, and the IOS Press Privacy Policy.

See instructions to authors.

Abstracted/Indexed in

Embase
Google Scholar
Scopus
Web of Science: Emerging Sources Citation Index

Sign Ups & Social Media – Be sure to sign up to the KCA journal newsletter to receive alerts of new issues and other journal news. Sign up via this link tiny.cc/KCAsignup & you can read the latest newsletter here. To follow us on social media, find our Twitter account at @KCA_Journal and keep updated as we share our journal content and news of interest to the kidney cancer research community. Join in the discussion with our research community!

Emerging Sources Citation Index – As of July 2021, Kidney Cancer is covered in the Emerging Sources Citation Index in the Web of Science.

APCs Waived – Article processing charges (APCs) are currently waived for Kidney Cancer and articles are published open access.

Kid. Can. Assoc. Partnership – As of Nov 2017, a new partnership was announced between the Kidney Cancer Association (kidneycancer.org) and our journal Kidney Cancer, which is a forum for important scientific advancements and the advocacy community.

KidCanAssoc banner on KCA

Sustainable Development Goals

This journal supports IOS Press' actions relating to the Sustainable Development Goals (SDGs) and commits to the Diversity and Inclusion Statement.

KCA geo data visual on dark blue background

More information will be available in due course. Check the SDGs page for updates.